AD
Clinical trials for AD explained in plain language.
Never miss a new study
Get alerted when new AD trials appear
Sign up with your email to follow new studies for AD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to slow Alzheimer's progression in major trial
Disease control Recruiting nowThis study is testing whether an experimental tablet called TTYP01 can slow the progression of early Alzheimer's disease. Researchers will enroll 180 people with mild memory problems due to Alzheimer's and randomly assign them to receive either one of two doses of TTYP01 or a pla…
Matched conditions: AD
Phase: PHASE2 • Sponsor: Shanghai Auzone Biological Technology Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug trial seeks to tame severe eczema itch and rash
Disease control Recruiting nowThis study is testing an investigational drug called ATI-045 to see if it can reduce the skin rash and severe itching of moderate-to-severe eczema (atopic dermatitis). About 96 adults who haven't gotten enough relief from standard creams will receive either the drug or a placebo …
Matched conditions: AD
Phase: PHASE2 • Sponsor: Aclaris Therapeutics, Inc. • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC